SENSEI BIOTHERAPEUTICS INC's ticker is SNSE and the CUSIP is 81728A108. A total of 32 filers reported holding SENSEI BIOTHERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $10,685 | +51.7% | 10,176 | 0.0% | 0.00% | – |
Q4 2023 | $7,042 | -19.1% | 10,176 | -6.4% | 0.00% | – |
Q3 2023 | $8,701 | -43.8% | 10,876 | -19.9% | 0.00% | – |
Q2 2023 | $15,477 | -32.5% | 13,576 | -11.1% | 0.00% | – |
Q1 2023 | $22,914 | -50.5% | 15,276 | -50.8% | 0.00% | – |
Q4 2022 | $46,303 | -15.8% | 31,076 | -13.1% | 0.00% | – |
Q3 2022 | $55,000 | -37.5% | 35,776 | -7.7% | 0.00% | – |
Q2 2022 | $88,000 | -38.9% | 38,776 | -37.6% | 0.00% | – |
Q1 2022 | $144,000 | -13.8% | 62,184 | +116.1% | 0.00% | – |
Q4 2021 | $167,000 | -7.7% | 28,771 | +55.1% | 0.00% | – |
Q2 2021 | $181,000 | -73.0% | 18,551 | -59.8% | 0.00% | -100.0% |
Q1 2021 | $670,000 | – | 46,112 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ikarian Capital, LLC | 650,000 | $403,065 | 0.07% |
Deuterium Capital Management, LLC | 11,000 | $6,821 | 0.01% |
BOOTHBAY FUND MANAGEMENT, LLC | 172,835 | $107,175 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 77,900 | $48,306 | 0.00% |
XTX Topco Ltd | 14,047 | $8,711 | 0.00% |
Leo Wealth, LLC | 14,845 | $9,205 | 0.00% |
NORTHERN TRUST CORP | 25,983 | $16,112 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
Cresset Asset Management, LLC | 19,671 | $12,198 | 0.00% |
Banque Cantonale Vaudoise | 3,900 | $2 | 0.00% |